]. Gastroenterol Clin North Am，2004，33：387406.
[14]Hanai H，Watanabe F，Takeuchi K，et al. Leukocyte adsorptive apheresis for the treatment of active ulcerative colitis：a prospective，uncont rolled pilot study[J]. Clin Gastroenterol Hepatol，2003，1：2835.
[15]Hanai H，Watanabe F，Saniabadi AR，et al. Therapeuticefficacy of granulocyte and monocyte adsorption apheresis insevere active ulcerative colitis[J]. Dig Dis Sci，2002，47：23492353.
[16]Suzuki Y，Yoshimura N，Saniabadi AR，et al. Selectivegranulocyte and monocyte adsorptive apheresis as a firstline treatment for steroid Naive patients with active ulcerative colitis：a prospective uncontrolled study[J]. Dig Dis Sci，2004，49：565571.
[17]Matsumoto T，Andoh A，Okawa K. Multivariate analysis for factors predicting rapid response of leukocytapheresis in patients with steroidresistant ulcerative colitis：a multicenter prospective openlabel study[J]. Ther Apher Dial，2008，12(6)：484490.
[18]Sigurbjrnsson FT，Bjarnason I. Leukocytapheresis for the treatment of IBD[J]. Nat Clin Pract Gastroenterol Hepatol，2008，5(9)：509516.
[19]Hanauer SB. Review article：the longterm management of ulcerative colitis[J]. Aliment Pharmacol Ther，2004，20(Supp14)：S97S101.
[20]Dotan I，Hallak A，Arber N，et al. lawdose lowmolecular weight heparin(e noxsparin)is efective as adjuvant treatment in active ulcerative coliits：mopentiral[J]. Digestive Diseases and Sciences，2001，46(10)：2239.
[21]Madsen SM，Schlichting P，Davidsen B，et al. An open-labeled, randomized study comparing systemic interon-alpha-2A and prednisolone enemas in the treatment of left-sided ulcerative colitis [J]. Am J Gastroentero1，2001，96(60)：18071815.
上一页 [1] [2] [3] [4] [5]
您现在的位置： 绿色健康网 >> 医学论文 >> 内科论文 >> 正文